
News|Articles|November 18, 2025
ADA Assays for Complex Molecule Development
Author(s)Prolytix
Having a robust immunogenicity assay for accurate evaluation of ADA in animal models is important for enabling effective decision-making during development. Learn how a robust anti-drug antibody assay was developed and was capable of detection at the requisite sensitivity and enabled meaningful interpretation of PK data obtained from the preclinical animal model.
Trending on Pharmaceutical Technology
1
What Jideytro's Approval Means for Drug Developers
2
Q&A : Brent Wilhelm on Supply Chains and Historical Demand Data
3
PharmTech Weekly Roundup—July 24, 2026
4
Midyear 2026 Check-In: AI Investment Skipped Pharma's Costliest Operational Problem
5